181 related articles for article (PubMed ID: 23065768)
1. Activation of rapid oestrogen signalling in aggressive human breast cancers.
Poulard C; Treilleux I; Lavergne E; Bouchekioua-Bouzaghou K; Goddard-Léon S; Chabaud S; Trédan O; Corbo L; Le Romancer M
EMBO Mol Med; 2012 Nov; 4(11):1200-13. PubMed ID: 23065768
[TBL] [Abstract][Full Text] [Related]
2. Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer.
Poulard C; Jacquemetton J; Trédan O; Cohen PA; Vendrell J; Ghayad SE; Treilleux I; Marangoni E; Le Romancer M
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195751
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival.
Bratton MR; Duong BN; Elliott S; Weldon CB; Beckman BS; McLachlan JA; Burow ME
Int J Oncol; 2010 Sep; 37(3):541-50. PubMed ID: 20664923
[TBL] [Abstract][Full Text] [Related]
4. Regulation of estrogen rapid signaling through arginine methylation by PRMT1.
Le Romancer M; Treilleux I; Leconte N; Robin-Lespinasse Y; Sentis S; Bouchekioua-Bouzaghou K; Goddard S; Gobert-Gosse S; Corbo L
Mol Cell; 2008 Jul; 31(2):212-21. PubMed ID: 18657504
[TBL] [Abstract][Full Text] [Related]
5. AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.
Bhat-Nakshatri P; Wang G; Appaiah H; Luktuke N; Carroll JS; Geistlinger TR; Brown M; Badve S; Liu Y; Nakshatri H
Mol Cell Biol; 2008 Dec; 28(24):7487-503. PubMed ID: 18838536
[TBL] [Abstract][Full Text] [Related]
6. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
[TBL] [Abstract][Full Text] [Related]
9. Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer.
Lee K; Liu Y; Mo JQ; Zhang J; Dong Z; Lu S
BMC Cancer; 2008 Jun; 8():158. PubMed ID: 18518979
[TBL] [Abstract][Full Text] [Related]
10. Molecular Insights of Pathways Resulting from Two Common PIK3CA Mutations in Breast Cancer.
Bhat-Nakshatri P; Goswami CP; Badve S; Magnani L; Lupien M; Nakshatri H
Cancer Res; 2016 Jul; 76(13):3989-4001. PubMed ID: 27197157
[TBL] [Abstract][Full Text] [Related]
11. LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer.
Bouchekioua-Bouzaghou K; Poulard C; Rambaud J; Lavergne E; Hussein N; Billaud M; Bachelot T; Chabaud S; Mader S; Dayan G; Treilleux I; Corbo L; Le Romancer M
Int J Cancer; 2014 Sep; 135(6):1307-18. PubMed ID: 24615515
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of phospho-Akt, phospho-BAD, HER2 and oestrogen receptors alpha and beta in Malaysian breast cancer patients.
Seow HF; Yip WK; Loh HW; Ithnin H; Por P; Rohaizak M
Pathol Oncol Res; 2010 Jun; 16(2):239-48. PubMed ID: 19882362
[TBL] [Abstract][Full Text] [Related]
13. Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cell.
Zhang F; Feng F; Yang P; Li Z; You J; Xie W; Gao X; Yang J
Int J Biochem Cell Biol; 2012 Feb; 44(2):320-6. PubMed ID: 22094188
[TBL] [Abstract][Full Text] [Related]
14. Non-tumorigenic epithelial cells secrete MCP-1 and other cytokines that promote cell division in breast cancer cells by activating ERα via PI3K/Akt/mTOR signaling.
Riverso M; Kortenkamp A; Silva E
Int J Biochem Cell Biol; 2014 Aug; 53():281-94. PubMed ID: 24878609
[TBL] [Abstract][Full Text] [Related]
15. The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer.
Mintz PJ; Habib NA; Jones LJ; Giamas G; Lewis JS; Bowen RL; Coombes RC; Stebbing J
Cancer; 2008 Sep; 113(6):1489-95. PubMed ID: 18615623
[TBL] [Abstract][Full Text] [Related]
16. Increase in hyaluronic acid degradation decreases the expression of estrogen receptor alpha in MCF7 breast cancer cell line.
Hanoux V; Eguida J; Fleurot E; Levallet J; Bonnamy PJ
Mol Cell Endocrinol; 2018 Nov; 476():185-197. PubMed ID: 29753772
[TBL] [Abstract][Full Text] [Related]
17. Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells.
Sudhagar S; Sathya S; Lakshmi BS
Br J Cancer; 2011 Sep; 105(7):953-60. PubMed ID: 21897387
[TBL] [Abstract][Full Text] [Related]
18. Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.
Deng L; Chen J; Zhong XR; Luo T; Wang YP; Huang HF; Yin LJ; Qiu Y; Bu H; Lv Q; Zheng H
PLoS One; 2015; 10(3):e0120511. PubMed ID: 25816324
[TBL] [Abstract][Full Text] [Related]
19. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
20. Cryptotanshinone inhibition of mammalian target of rapamycin pathway is dependent on oestrogen receptor alpha in breast cancer.
Pan Y; Shi J; Ni W; Liu Y; Wang S; Wang X; Wei Z; Wang A; Chen W; Lu Y
J Cell Mol Med; 2017 Sep; 21(9):2129-2139. PubMed ID: 28272775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]